Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes

Trial Profile

Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin suspension isophane
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms PREDICTIVE-BMI
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 03 Jul 2009 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
    • 08 Aug 2008 Results were published in Diabetic Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top